Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.

Lin CW, Lin CC, Mo LR, Chang CY, Perng DS, Hsu CC, Lo GH, Chen YS, Yen YC, Hu JT, Yu ML, Lee PH, Lin JT, Yang SS.

J Hepatol. 2013 Apr;58(4):730-5. doi: 10.1016/j.jhep.2012.11.045.

PMID:
23220252
2.

Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.

Kwon OS, Jung YK, Kim YS, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS, Chun BC, Kim JH.

Korean J Hepatol. 2010 Sep;16(3):308-14. doi: 10.3350/kjhep.2010.16.3.308.

3.

Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.

Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11.

PMID:
17559381
4.

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Fattovich G, Stroffolini T, Zagni I, Donato F.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. Review.

PMID:
15508101
5.

Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A.

J Viral Hepat. 2013 Jul;20(7):502-9. doi: 10.1111/jvh.12054.

PMID:
23730844
6.

[A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].

Chung NS, Kwon OS, Park CH, Kim YN, Cho GH, Lee JJ, Kim GH, Kim HO, Ko KI, Yu SK, Kwon KA, Kim YS, Choi DJ, Kim JH.

Korean J Gastroenterol. 2007 Jun;49(6):369-75. Korean.

7.

What can we learn from hepatitis B virus clinical cohorts?

Lin CL, Tseng TC, Kao JH.

Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Review.

PMID:
25529093
8.

High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.

Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.

J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8.

PMID:
17914971
9.

High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K.

J Gastroenterol Hepatol. 2004 Jun;19(6):670-5.

PMID:
15151623
10.

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.

Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK; HEPNET. Greece Cohort Study Group..

Gut. 2011 Aug;60(8):1109-16. doi: 10.1136/gut.2010.221846.

PMID:
21270118
11.

Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.

Kubicka S, Rudolph KL, Hanke M, Tietze MK, Tillmann HL, Trautwein C, Manns M.

Liver. 2000 Jul;20(4):312-8.

PMID:
10959810
12.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
13.

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.

Kurokawa M, Hiramatsu N, Oze T, Yakushijin T, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Ishida H, Tatsumi T, Kiso S, Kanto T, Kasahara A, Iio S, Doi Y, Yamada A, Oshita M, Kaneko A, Mochizuki K, Hagiwara H, Mita E, Ito T, Inui Y, Katayama K, Yoshihara H, Imai Y, Hayashi E, Hayashi N, Takehara T.

J Gastroenterol. 2012 May;47(5):577-85. doi: 10.1007/s00535-011-0522-7.

PMID:
22231575
14.

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN.

Hepatology. 2010 Jun;51(6):1972-8. doi: 10.1002/hep.23527.

PMID:
20209604
15.
16.

Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.

Cho JY, Paik YH, Sohn W, Cho HC, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409.

PMID:
24615378
17.

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Liu J, Chen CJ.

PLoS One. 2013 Apr 17;8(4):e61448. doi: 10.1371/journal.pone.0061448.

18.

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007.

PMID:
22333950
19.

Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.

Wan DW, Tzimas D, Smith JA, Kim S, Araujo J, David R, Lobach I, Sarpel U.

Am J Gastroenterol. 2011 Nov;106(11):1994-2000. doi: 10.1038/ajg.2011.302.

PMID:
21912436
20.

[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].

Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.

Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67. Korean.

Items per page

Supplemental Content

Support Center